Skip to content

Neurofunctional Physical Therapy in Parkinson's disease: a feasibility trial

Neurofunctional Physical Therapy in Parkinson's disease: assessments tools and answer to physiotherapy intervention

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-8n94qg
Enrollment
Unknown
Registered
2017-01-09
Start date
2016-11-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nervous system diseases, Pathological conditions, signs and symptoms, Parkinson's disease.

Interventions

Group 1: 10 individuals with Parkinson's disease with freezing of gait
Group 2:10 individuals with Parkinson's disease without freezing of gait. The mixed gait training protocol integrating dual cognitive and motor tasks will be execute in 8 meters track, performed 3 t
Behavioural
E02.779.483

Sponsors

Universidade do Estado de Santa Catarina
Lead Sponsor
University of Miami Miller School of Medicine
Collaborator

Eligibility

Age
50 Years to 90 Years

Inclusion criteria

Inclusion criteria: Individuals diagnosed with Parkinson's disease confirmed by the neurologist according to London Brain Bank criteria (Hughes et al., 1992); 50-90 years, mild to moderate staging of disease (stages 1 to 3 according to the Hoehn and Yahr Scale); stable medication (on the same medication / dose for at least 4 weeks); cognitive level related to scholarity level (in Mini Mental State Exam).

Exclusion criteria

Exclusion criteria: Patients presenting other neurological disorders associated; presenting orthopedic pathologies and / or joint limitations that affect the musculoskeletal system and make it difficult and / or difficult to perform the training; individuals who can not perform walking independently.

Design outcomes

Primary

MeasureTime frame
Expected outcome: Protocol viability. Variables: Execution safety (measured in percentage through the occurrence of serious imbalances that compromise the safety of the participants during the intervention, being considered as a limit a percentage of 20% of occurrences), adherence to the treatment (measured as percentage by attendance frequency Of the participants to the treatment sessions, being considered as a minimum percentage of 80% for each participant). For purposes of sample calculation, the mean and standard deviation of the freezing gait score will be used as the primary outcome, assessed by the freezing of gait questionnaire (which contains 6 questions regarding the severity and frequency of the freezing).

Secondary

MeasureTime frame
Effects of gait protocol on: gait velocity (evaluated through the 10-meter walk test, widely used and recommended for gait speed assessment in Parkinson's disease), functional mobility in single task and double task, through the test Timed Up and Go test in single and double task.To test the effect caused by the intervention will be used statistical tests according to the distribution of the data. The level of significance of 5% (p <0.05) will be adopted in all tests.

Countries

Brazil

Contacts

Public ContactAlessandra Swarowsky

Universidade do Estado de Santa Catarina

alessandra.martin@udesc.br+55 48 36648605

Outcome results

None listed

Source: REBEC (via WHO ICTRP)